Dr. Kristin Follman joined Certara as a Clinical Pharmacologist in 2019. She supports preclinical and clinical drug development for both biologics and small molecules across a large range of indications. Dr. Follman has experience in pharmacokinetics (PK) and pharmacodynamics (PD), exposure response, population PK modeling and DMPK.
Prior to joining Certara, Dr. Follman obtained her PhD in Pharmaceutical Sciences from the University at Buffalo where her research investigated the treatment of overdose for drugs of abuse. Her work included assay development, in vitro and in vivo study design and mechanistic pharmacokinetic modeling.